198 related articles for article (PubMed ID: 18379994)
21. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
[TBL] [Abstract][Full Text] [Related]
22. Bisphenol A modifies the regulation exerted by testosterone on 5 α -reductase isozymes in ventral prostate of adult rats.
Sánchez P; Castro B; Torres JM; Olmo A; del Moral RG; Ortega E
Biomed Res Int; 2013; 2013():629235. PubMed ID: 23984391
[TBL] [Abstract][Full Text] [Related]
23. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.
Pelletier G; Luu-The V; Huang XF; Lapointe H; Labrie F
J Urol; 1998 Aug; 160(2):577-82. PubMed ID: 9679931
[TBL] [Abstract][Full Text] [Related]
24. Region-specific expression of androgen and growth factor pathway genes in the rat epididymis and the effects of dual 5alpha-reductase inhibition.
Henderson NA; Cooke GM; Robaire B
J Endocrinol; 2006 Sep; 190(3):779-91. PubMed ID: 17003279
[TBL] [Abstract][Full Text] [Related]
25. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
[TBL] [Abstract][Full Text] [Related]
26. Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.
Thomas LN; Lazier CB; Gupta R; Norman RW; Troyer DA; O'Brien SP; Rittmaster RS
Prostate; 2005 May; 63(3):231-9. PubMed ID: 15538746
[TBL] [Abstract][Full Text] [Related]
27. 5alpha-reductase isoenzymes 1 and 2 in the rat testis during postnatal development.
Killian J; Pratis K; Clifton RJ; Stanton PG; Robertson DM; O'Donnell L
Biol Reprod; 2003 May; 68(5):1711-8. PubMed ID: 12606426
[TBL] [Abstract][Full Text] [Related]
28. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
Rittmaster RS
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
[TBL] [Abstract][Full Text] [Related]
29. Nerve growth factor induces elevation of steroid 5alpha-reductase mRNA levels in rat C6 glioma cells through expression of transcription factor Egr-1.
Her S; Arimochi H; Morita K
Brain Res Mol Brain Res; 2004 Jul; 126(2):157-64. PubMed ID: 15249139
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.
Makridakis N; Akalu A; Reichardt JK
Oncogene; 2004 Sep; 23(44):7399-405. PubMed ID: 15326487
[TBL] [Abstract][Full Text] [Related]
31. Regulation of prostate 5alpha-reductase-2 gene expression and prostate weight by dietary fat and caloric intake in the rat.
Cai LQ; Imperato-McGinley J; Zhu YS
Prostate; 2006 May; 66(7):738-48. PubMed ID: 16425201
[TBL] [Abstract][Full Text] [Related]
32. Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5alpha-reductase inhibitors.
Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
Steroids; 2010 Jun; 75(6):411-8. PubMed ID: 20170668
[TBL] [Abstract][Full Text] [Related]
33. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
Ye L; Zhang Y; Fang Z
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1504-7. PubMed ID: 16200776
[TBL] [Abstract][Full Text] [Related]
34. Actions of 5alpha-reductase inhibitors on the epididymis.
Robaire B; Henderson NA
Mol Cell Endocrinol; 2006 May; 250(1-2):190-5. PubMed ID: 16476520
[TBL] [Abstract][Full Text] [Related]
35. Steroid 5α-reductase in adult rat brain after neonatal testosterone administration.
Sánchez P; Torres JM; del Moral RG; de Dios Luna J; Ortega E
IUBMB Life; 2012 Jan; 64(1):81-6. PubMed ID: 22131296
[TBL] [Abstract][Full Text] [Related]
36. Hyperprolactinemia and 5-alpha-reductase activity.
Noci I; Tantini C; Nardi E; Saltarelli O; Chelo E; Scarselli G; Bigazzi M; Messori A
Acta Eur Fertil; 1986; 17(2):129-31. PubMed ID: 2943108
[TBL] [Abstract][Full Text] [Related]
37. Regional distribution of 5alpha-reductase type 1 and type 2 mRNA along the nonhuman primate (Macaca fascicularis) epididymis.
Mahony MC; Heikinheimo O; Gordon K; Hodgen GD
J Androl; 1997; 18(6):595-601. PubMed ID: 9432132
[TBL] [Abstract][Full Text] [Related]
38. Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.
Thomas LN; Douglas RC; Lazier CB; Too CK; Rittmaster RS; Tindall DJ
Eur Urol; 2008 Feb; 53(2):244-52. PubMed ID: 18006217
[TBL] [Abstract][Full Text] [Related]
39. Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.
Van Coppenolle F; Slomianny C; Carpentier F; Le Bourhis X; Ahidouch A; Croix D; Legrand G; Dewailly E; Fournier S; Cousse H; Authie D; Raynaud JP; Beauvillain JC; Dupouy JP; Prevarskaya N
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E120-9. PubMed ID: 11120666
[TBL] [Abstract][Full Text] [Related]
40. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
Assinder SJ
Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
